Order Article Reprints

Lomelí-Nieto JA, Muñoz-Valle JF, Navarro-Zarza JE, Baños-Hernández CJ, Gutierrez-Brito JA, Renteria-Cabrera V, Horta-Chávez EA, Morales-Núñez JJ, García-Arellano S, Parra-Rojas I, et al. Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population. Life. 2024; 14(9):1056. https://doi.org/10.3390/life14091056

Lomelí-Nieto, José Alvaro, José Francisco Muñoz-Valle, José Eduardo Navarro-Zarza, Christian Johana Baños-Hernández, Jesús Alberto Gutierrez-Brito, Valeria Renteria-Cabrera, Eduardo Arturo Horta-Chávez, José Javier Morales-Núñez, Samuel García-Arellano, Isela Parra-Rojas, and et al. 2024. "Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population" Life 14, no. 9: 1056. https://doi.org/10.3390/life14091056

Lomelí-Nieto, J. A., Muñoz-Valle, J. F., Navarro-Zarza, J. E., Baños-Hernández, C. J., Gutierrez-Brito, J. A., Renteria-Cabrera, V., Horta-Chávez, E. A., Morales-Núñez, J. J., García-Arellano, S., Parra-Rojas, I., & Hernández-Bello, J. (2024). Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population. Life, 14(9), 1056. https://doi.org/10.3390/life14091056